Michael McCord
CEO @ alumshares
Raleigh, United States
Michael McCord is a Series A investor at alumshares in Raleigh focused on Therapeutics and Biotechnology. Michael McCord is the CEO at Alumshares.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Michael McCord invests in
Stages Michael McCord invests in
Countries Michael McCord invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Product Research 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies),encapsulation (for sustained/controlled release), or dry powder pulmonary delivery. | $1.6M / Series A / Sep 18, 2019 |
Co-Investors
BlueTree Allied Angels
1 deal together
Charleston Angel Conference
1 deal together
IAG Capital Partners
1 deal together
Next Act Fund
1 deal together
About alumshares
alumshares connects alumni of premier research institutions with previously inaccessible investment opportunities at their Alma Mater.
alumshares Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Michael McCord
CEO
|
|||
Chris Keenan
Principal Software Engineer
|
|||
|
Omar Flores
PhD
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Michael McCord invest in?
Michael McCord invests primarily in Therapeutics, Biotechnology and Product Research startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Michael McCord?
Public channels for Michael McCord include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Michael McCord last invest?
The most recent investment recorded for Michael McCord closed in Sep 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
